EFSA | 29th Meeting Of The Working Group On The Reevaluation Of Sweeteners | 28 January 2021 | Minutes


Your substances

None

This news contains references also to other Substances


The Minutes Of The 29th Meeting Of The Working Group On The Reevaluation Of Sweeteners includes the following scientific topics for discussion:

5.1 Implementation of the protocol

A discussion on how to perform the next steps on data extraction and weight of evidence, according to the protocol on hazard identification and characterisation, took place. Next steps to move forward were noted.

The main points of discussion will be implemented on the draft opinion on thaumatin (E 957) as a pilot.

5.2 Thaumatin (E 957) EFSA-Q-2011-00725

The results on the exposure assessment of thaumatin (E 957) were discussed.

Technical data: a discussion on some aspects of the technical part of the draft opinion on thaumatin (E 957), following the information received by interested business operators, took place.

Toxicological data: some clarifications on the risk of bias tables for both animals and human studies on thaumatin (E 957) were discussed. The genotoxicity section of the draft opinion on thaumatin was also discussed.

Next steps to move forward were noted. This draft opinion will be discussed in a forthcoming WG meeting.

5.3. Neotame (E 961) EFSA-Q-2011-00740

The results of the exposure assessment of neotame (E 961) were discussed.

Technical data: a discussion on some aspects of the technical part of the draft opinion on neotame (E 961), following the information received by the interested business operator, took place.

Other parts of the draft opinion (e.g. Discussion) were also discussed as well as the outcome of the updated literature search.

Next steps to move forward were noted. This draft opinion will be discussed in a forthcoming WG meeting

5.4 Sucralose (E 955) EFSA-Q-2011-00724

The results on the exposure assessment of sucralose (E 955) were discussed.

Toxicological data: the relevance of some of the toxicity studies, included after the screening for relevance step of the protocol, was discussed.

An update on some changes applied in the Distiller tools were also presented.

Next steps to move forward were noted. This draft opinion will be discussed in a forthcoming WG meeting.

5.5 Neohesperidine DC (E 959) EFSA-Q-2011-00726

The results on the exposure assessment of neohesperidine DC (E 959) were discussed.

Some issues on the data available were presented to the WG and the steering on the next steps to move forward were noted.

This draft opinion will be discussed in a forthcoming WG meeting.


Link to the:  Minutes Of The 29th Meeting Of The Working Group On The Reevaluation Of Sweeteners


 
                   

Related News

Loading...